Health Canada. Opioid- and stimulant-related harms — Canada.ca. Published 2023. Accessed July 19, 2023. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/

Ayoo K, Mikhaeil J, Huang A, Wąsowicz M. The opioid crisis in North America: facts and future lessons for Europe. Anaesthesiol Intensive Ther. 2020;52(2):139–47. https://doi.org/10.5114/ait.2020.94756.

Article  PubMed  PubMed Central  Google Scholar 

BC Gov News. Provincial health officer declares public health emergency | BC Gov News. Published April 14, 2016. Accessed February 5, 2024. https://news.gov.bc.ca/releases/2016HLTH0026-000568

Pauly B, Wallace B, Pagan F, et al. Impact of overdose prevention sites during a public health emergency in Victoria. Canada PLoS One. 2020;15(5):e0229208. https://doi.org/10.1371/journal.pone.0229208.

Article  CAS  PubMed  Google Scholar 

Health Canada. Supervised consumption explained: types of sites and services. Published May 15, 2018. Accessed July 31, 2023. https://www.canada.ca/en/health-canada/services/substance-use/supervised-consumption-sites/explained.html

Canadian Centre on Substance Use and Addiction. The availability of take-home naloxone in Canada.; 2016. https://www.ccsa.ca/sites/default/files/2019-05/CCSA-CCENDU-Take-Home-Naloxone-Canada-2016-en.pdf. Accessed 12 Sept 2023.

Foreman-Mackey A, Pauly B, Ivsins A, Urbanoski K, Mansoor M, Bardwell G. Moving towards a continuum of safer supply options for people who use drugs: a qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada. Subst Abuse Treat Prev Policy. 2022;17(1):66. https://doi.org/10.1186/s13011-022-00494-y.

Article  PubMed  PubMed Central  Google Scholar 

Weicker SA, Speed KA, Hyshka E, Mrochuk M, Kosteniuk B, Dong K. Emergency department care for patients who use opioids during the COVID-19 pandemic. Can J Emerg Med. 2022;24(2):123–5. https://doi.org/10.1007/s43678-021-00229-1.

Article  Google Scholar 

Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): a national qualitative study. J Subst Abuse Treat. 2021;129:108374. https://doi.org/10.1016/j.jsat.2021.108374.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cassie R, Hayashi K, DeBeck K, et al. Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada. Harm Reduct J. 2022;19(1):126. https://doi.org/10.1186/s12954-022-00712-7.

Article  PubMed  PubMed Central  Google Scholar 

Minoyan N, Høj SB, Zolopa C, Vlad D, Bruneau J, Larney S. Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada. Harm Reduct J. 2022;19(1):38. https://doi.org/10.1186/s12954-022-00620-w.

Article  PubMed  PubMed Central  Google Scholar 

Canadian Centre on Substance Use and Addiction. Impacts of the COVID-19 Pandemic on Substance Use Treatment Capacity in Canada. Published online 2020. https://www.ccsa.ca/impacts-covid-19-pandemic-substance-use-treatment-capacity-canada. Accessed 12 Sept 2023.

Alberta Health Services. Spike in opioid overdose calls prompts public warning. Alberta Health Services. Published 2019. https://www.albertahealthservices.ca/news/Page14902.aspx. Accessed 3 Feb 2024.

Vancouver Coastal Health. Overdose response, Naloxone & training | Vancouver Coastal Health. Accessed February 3, 2024. https://www.vch.ca/en/overdose-response-naloxone-training

Health Canada. Modelling opioid-related deaths during the overdose crisis. Published November 26, 2020. Accessed February 21, 2024. https://www.canada.ca/en/health-canada/services/opioids/data-surveillance-research/modelling.html

Russell C, Law J, Bonn M, Rehm J, Ali F. The increase in benzodiazepine-laced drugs and related risks in Canada: the urgent need for effective and sustainable solutions. Int J Drug Policy. 2023;111:103933. https://doi.org/10.1016/j.drugpo.2022.103933.

Article  PubMed  Google Scholar 

Perri M, Kaminski N, Bonn M, et al. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone. Harm Reduct J. 2021;18(1):85. https://doi.org/10.1186/s12954-021-00530-3.

Article  PubMed  PubMed Central  Google Scholar 

NORS. National Overdose Response Service. NORS. https://www.nors.ca/about. Accessed 10 Jan 2024.

Brave. Brave Coop. https://brave.coop/. Accessed 17 Jan 2024.

Never Use Alone. Never Use Alone – No Judgment, No Shaming, No Preaching, Just LOVE! https://neverusealone.com/. Accessed 13 Dec 2023.

Lifeguard Digital Health Inc. Lifeguard Digital Health. https://lifeguarddh.com/. Accessed 17 Jan 2024.

Digital Overdose Response System. DORS. https://www.dorsapp.ca. Accessed 17 Jan 2024.

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191. https://doi.org/10.1001/jama.2013.281053.

Article  CAS  Google Scholar 

Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237. https://doi.org/10.1016/j.drugpo.2021.103237.

Article  PubMed  PubMed Central  Google Scholar 

Urrutia D, Manetti E, Williamson M, Lequy E. Overview of Canada’s answer to the COVID-19 pandemic’s first wave (January–April 2020). Int J Environ Res Public Health. 2021;18(13):7131. https://doi.org/10.3390/ijerph18137131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghose R, Forati AM, Mantsch JR. Impact of the COVID-19 pandemic on opioid overdose deaths: a spatiotemporal analysis. J Urban Health. 2022;99(2):316–27. https://doi.org/10.1007/s11524-022-00610-0.

Article  PubMed  PubMed Central  Google Scholar 

Butler A, Croxford R, McLeod KE, et al. The impact of COVID-19 on opioid toxicity deaths for people who experience incarceration compared to the general population in Ontario: a whole population data linkage study. PLoS One. 2023;18(10):e0293251. https://doi.org/10.1371/journal.pone.0293251.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cowan E, Khan MR, Shastry S, Edelman EJ. Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model. Addict Sci Clin Pract. 2021;16(1):4. https://doi.org/10.1186/s13722-020-00210-w.

Article  PubMed  PubMed Central  Google Scholar 

Schneider KE, Allen ST, Rouhani S, et al. Increased solitary drug use during COVID-19: an unintended consequence of social distancing. Int J Drug Policy. 2023;111:103923. https://doi.org/10.1016/j.drugpo.2022.103923.

Article  PubMed  Google Scholar 

Mental Health Commission of Canada. Mental health and substance use during COVID-19: spotlight on youth, older adults & stigma. Mental Health Commission of Canada. Published August 10, 2023. Accessed August 10, 2023. https://mentalhealthcommission.ca/resource/poll-covid-19-youth-older-adults-stigma/

Shankar R, Bhattacharya V. Trends in substance use and abuse during COVID-19 among the general population. Addict Health. 2022;14(4):296–308. https://doi.org/10.34172/ahj.2022.1274.

Article  PubMed  PubMed Central  Google Scholar 

Husak L, Sovran V, Ytsma A, Comeau M. Impact of the COVID-19 pandemic on virtual care: a major shift for physicians and patients. Healthc Q. 2022;25(3):11–3. https://doi.org/10.12927/hcq.2022.26948.

Article  PubMed  Google Scholar 

Perri M, Guta A, Gagnon M, et al. Developing a digital health strategy for people who use drugs: lessons from COVID-19. Digit Health. 2021;7:205520762110284. https://doi.org/10.1177/20552076211028404.

Article  Google Scholar 

Tsang VWL, Papamihali K, Crabtree A, Buxton JA. Acceptability of technological solutions for overdose monitoring: perspectives of people who use drugs. Subst Abuse. 2021;42(3):284–93. https://doi.org/10.1080/08897077.2019.1680479.

Article  CAS  Google Scholar 

Bardwell G, Strike C, Mitra S, et al. “That’s a double-edged sword”: exploring the integration of supervised consumption services within community health centres in Toronto. Canada Health Place. 2020;61:102245. https://doi.org/10.1016/j.healthplace.2019.102245.

Article  PubMed  Google Scholar 

Muncan B, Walters SM, Ezell J, Ompad DC. “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53. https://doi.org/10.1186/s12954-020-00399-8.

Article  PubMed  PubMed Central  Google Scholar 

Bowles JM, Kolla G, Smith LR, Scheim A, Dodd Z, Werb D. Disease-related stigma among people who inject drugs in Toronto amidst the COVID-19 pandemic. Drug Alcohol Depend Rep. 2023;7:100167. https://doi.org/10.1016/j.dadr.2023.100167.

Article  PubMed  PubMed Central  Google Scholar 

Public Health Agency of Canada. Government of Canada to remove COVID-19 border and travel measures effective October 1. Published September 25, 2022. Accessed August 21, 2023. https://www.canada.ca/en/public-health/news/2022/09/government-of-canada-to-remove-covid-19-border-and-travel-measures-effective-october-1.html

Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. The Lancet. 2011;377(9775):1429–37. https://doi.org/10.1016/S0140-6736(10)62353-7.

Article  Google Scholar 

Fernandes RM, Cary M, Duarte G, et al. Effectiveness of needle and syringe programmes in people who inject drugs – An overview of systematic reviews. BMC Public Health. 2017;17(1):309. https://doi.org/10.1186/s12889-017-4210-2.

Article  PubMed  PubMed Central  Google Scholar 

Rammohan I, Gaines T, Scheim A, Bayoumi A, Werb D. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis. Lancet Public Health. 2024;9(2):e79–87. https://doi.org/10.1016/S2468-2667(23)00300-6.

Article  PubMed  Google Scholar 

Strike C, Miskovic M. Scoping out the literature on mobile needle and syringe programs—review of service delivery and client characteristics, operation, utilization, referrals, and impact. Harm Reduct J. 2018;15(1):6. https://doi.org/10.1186/s12954-018-0212-3.

Article  PubMed  PubMed Central  Google Scholar